Drug General Information (ID: DDIUABHGWC)
  Drug Name Altretamine Drug Info Doxepin Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antineoplastics Antidepressants
  Structure

 Mechanism of Altretamine-Doxepin Interaction (Severity Level: Moderate)
     Additive hypotensive effects Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Altretamine Doxepin
      Mechanism 1 Hypotensive effects Antihypertensive agent
      Key Mechanism Factor 1
Factor Name Hypotensive effects
Factor Description Hypotension is a blood pressure reading below the prescribed limit (90/60 mmHg). Symptoms of hypotension may include: blurred or faded vision , dizziness or light-headedness, fainting , fatigue , difficulty concentrating, nausea.
      Mechanism Description
  • Additive hypotensive effects by the combination of Altretamine and Doxepin 
      Mechanism 2 Hypotensive effects Hypotensive effects
      Key Mechanism Factor 2
Factor Name Hypotensive effects
Factor Description Hypotension is a blood pressure reading below the prescribed limit (90/60 mmHg). Symptoms of hypotension may include: blurred or faded vision , dizziness or light-headedness, fainting , fatigue , difficulty concentrating, nausea.
      Mechanism Description
  • Additive hypotensive effects by the combination of Altretamine and Doxepin 

Recommended Action
      Management Caution is advised if altretamine must be used with a MAOI or tricyclic antidepressant, particularly in elderly patients. All patients receiving the combination should be advised to avoid rising abruptly from a sitting or lying position and to contact their physician if they experience symptoms of hypotension such as dizziness, lightheadedness, or fainting.

References
1 Bruckner HW, Schleifer SJ "Orthostatic hypotension as a complication of hexamethylmelamine antidepressant interaction." Cancer Treat Rep 67 (1983): 516. [PMID: 6406063]
2 Product Information. Hexalen Capsules (altretamine). US Bioscience, West Conshohoken, PA.